- Home
- CYH vs VALN Comparison
CYH vs VALN Comparison
Compare CYH & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYH
- VALN
- Stock Information
- Founded
- CYH 1985
- VALN 2012
- Country
- CYH United States
- VALN France
- Employees
- CYH N/A
- VALN N/A
- Industry
- CYH Hospital/Nursing Management
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CYH Health Care
- VALN Health Care
- Exchange
- CYH Nasdaq
- VALN Nasdaq
- Market Cap
- CYH 482.7M
- VALN 548.5M
- IPO Year
- CYH 1991
- VALN 2021
- Fundamental
- Price
- CYH $2.80
- VALN $7.73
- Analyst Decision
- CYH Hold
- VALN Strong Buy
- Analyst Count
- CYH 9
- VALN 3
- Target Price
- CYH $4.19
- VALN $15.33
- AVG Volume (30 Days)
- CYH 3.4M
- VALN 32.0K
- Earning Date
- CYH 07-23-2025
- VALN 08-12-2025
- Dividend Yield
- CYH N/A
- VALN N/A
- EPS Growth
- CYH N/A
- VALN N/A
- EPS
- CYH N/A
- VALN N/A
- Revenue
- CYH $12,647,000,000.00
- VALN $201,099,222.00
- Revenue This Year
- CYH N/A
- VALN $18.74
- Revenue Next Year
- CYH $3.16
- VALN $29.26
- P/E Ratio
- CYH N/A
- VALN N/A
- Revenue Growth
- CYH 0.81
- VALN 21.64
- 52 Week Low
- CYH $2.24
- VALN $3.62
- 52 Week High
- CYH $6.29
- VALN $8.66
- Technical
- Relative Strength Index (RSI)
- CYH 31.21
- VALN 79.20
- Support Level
- CYH $2.68
- VALN $5.95
- Resistance Level
- CYH $3.97
- VALN $8.50
- Average True Range (ATR)
- CYH 0.17
- VALN 0.36
- MACD
- CYH -0.07
- VALN 0.19
- Stochastic Oscillator
- CYH 12.71
- VALN 73.67
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.